Josh Bauml, MD, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and the Veteran’s Administration Medical Center joins GRACE to share the following information regarding Head and Neck Cancers
Head & Neck Cancers
Frequently Asked Questions
Written by Joshua Bauml, MD
September 2017
What is it?
“Head and neck cancer” is an umbrella term for different cancers that occur in the head and neck region, from the sinuses and nasal cavity down to the larynx. The most common of these tumors affect the lining of the mouth and throat. Head and neck cancers are divided by where they start:
Some of the most common presenting symptoms are a lump or swelling in the neck, a sore or spot in the mouth that does not heal, a lingering sore throat, pain or an inability to swallow, or a change in voice.
There are three major risk factors for head and neck cancer
Your team of medical professionals should include medical and radiation oncologists, plastic surgeons specializing in the head, neck, and dental regions, a dietician, and a speech pathologist.
Your treatment will vary depending on the location of the primary cancer, its stage, and your age. Treatment may include surgery, radiation, chemotherapy, and targeted therapy. At this time, immunotherapy is only used in metastatic, or stage IV, head and neck cancer.
See:
Side effects from head and neck cancer treatments depend on the treatment
See also:
Every patient tolerates treatment differently. If you are receiving chemo-radiotherapy or radiation, you will likely have treatment five days per week for about seven weeks which can make it difficult to continue working full-time. Also, towards the end of treatment, side effects can accumulate, making work difficult. If you are receiving surgery, many patients can go back to work shortly after the surgical recovery. If you are receiving chemotherapy alone, it depends upon the regimen used. Talk to your doctor for more individualized advice.
Don’t see your question here? Log on to the GRACE message boards and post it there.
Please feel free to offer comments and raise questions in our Discussion Forums.
![]() Dr. Jared Weiss, University of North Carolina School of Medicine |
![]() Dr. Siddharth Sheth, University of North Carolina |
![]() Joshua Bauml, MD, University of Pennsylvania |
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers. In this roundtable video, the doctors discuss New Data from ASCO 2017 on Weekly Cisplatin Regimens.
|
||
Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
![]() Dr. Jared Weiss, University of North Carolina School of Medicine |
![]() Dr. Siddharth Sheth, University of North Carolina |
![]() Joshua Bauml, MD, University of Pennsylvania |
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers. In this roundtable video, the doctors discuss HPV Vaccination, Possible Prevention of an Epidemic of Head and Neck Cancer.
|
||
Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
![]() Dr. Jared Weiss, University of North Carolina School of Medicine |
![]() Dr. Siddharth Sheth, University of North Carolina |
![]() Joshua Bauml, MD, University of Pennsylvania |
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers. In this roundtable video, the doctors discuss Combination Immunotherapy.
|
||
Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
![]() Dr. Jared Weiss, University of North Carolina School of Medicine |
![]() Dr. Siddharth Sheth, University of North Carolina |
![]() Joshua Bauml, MD, University of Pennsylvania |
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers. In this roundtable video, the doctors discuss Immunotherapy Limitations and Ideas on How to Improve It.
|
||
Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
Recent Comments